Industry News
Osteoporosis Drug Bazedoxifene Stops Growth Of Breast Cancer Cells
Jun 17, 2013
Bazedoxifene, an osteoporosis medication which is approved in Europe, stops the growth of breast cancer cells, including those that are resistant to current medications, researchers from the Duke Cancer Institute reported at ENDO 2013 - The Endocrine Society's Annual Meeting in San Francisco, California, June 15th, 2013... Read More
Identifying Women Most Likely To Respond To Preventive Breast Cancer Therapy
Jun 17, 2013
Newly discovered genetic variations may help predict breast cancer risk in women who receive preventive breast cancer therapy with the selective estrogen receptor modulator drugs tamoxifen and raloxifene, a Mayo Clinic-led study has found. The study is published in the journal Cancer Discovery... Read More
Greater Potential Benefit In Overall Survival For Eribulin Compared With Capecitabine For Metastatic Breast Cancer
Jun 17, 2013
Subgroup analyses from a phase III clinical trial comparing a newer chemotherapy agent called eribulin mesylate, with capecitabine, a standard chemotherapy medication in women with previously treated metastatic breast cancer, showed increased benefit among women sharing certain traits... Read More
Researchers Succeed In Programming Blood Forming Stem Cells
Jun 17, 2013
By transferring four genes into mouse fibroblast cells, researchers at the Icahn School of Medicine at Mount Sinai have produced cells that resemble hematopoietic stem cells, which produce millions of new blood cells in the human body every day... Read More
South Asian Women Have Higher Breast Cancer Risk Than White Women, UK
Jun 16, 2013
South Asian women in Britain have an 8% higher risk of developing breast cancer than British white women, compared to a 45% lower risk ten years ago, researchers from the University of Sheffield reported at the National Cancer Intelligence Network Conference in Brighton on Friday, June 14th. Study leader, Dr... Read More
Drug Action In Pancreatic Cancer Tracked And Improved By Nanotechnology
Jun 15, 2013
UK and Australian scientists have been able to show ways in which we can markedly improve drug targeting of solid tumours, using tiny 'biosensors' along with new advanced imaging techniques. In real time and in three dimensions, these technologies can show us how cancers spread and how active cancer cells respond to a particular drug... Read More
Firmer Silicon Gel Implant Gets FDA Go Ahead
Jun 15, 2013
The FDA has approved the firmer MemoryShape Breast Implants for breast augmentation in women aged 22 years or more, and for females of any age who require breast reconstruction. The MemoryShape Breast Implants are manufactured and marketed by Mentor Worldwide LLC, Santa Barbara, California... Read More
First Guidelines For Treating Non-Transfusion-Dependent Thalassaemia Introduced At European Haematology Association Meeting
Jun 15, 2013
New guidelines released by the Thalassaemia International Federation (TIF) address the Management of Non-Transfusion Dependent Thalassaemias (NTDT) and are a first of their kind in the field of medical haematology... Read More
PAHO/WHO Urges Countries Of The Americas To Work Toward 100% Voluntary Altruistic Blood Donation
Jun 14, 2013
In Latin America and the Caribbean, only 41% of blood supplies are obtained through voluntary altruistic blood donation, the safest way to collect blood, according to the Pan American Health Organization/World Health Organization (PAHO/WHO)... Read More
New Sickle Cell Anemia Therapy Advances To Phase II Clinical Trials
Jun 14, 2013
Seeking to improve the lives of sickle cell anemia sufferers around the world, researchers from the La Jolla Institute for Allergy and Immunology, the Dana-Farber/Children's Hospital Cancer Center in Boston and the BloodCenter of Wisconsin in Milwaukee and others are preparing to launch Phase II of a clinical trial to investigate a potential new therapy for reducing the disor... Read More
Previous Page Next Page